AUROBINDO PHARMA : STEP-DOWN SUBSIDIARY ACQUIRES 20% STAKE IN A1 BIOCHEM LABS (INDIA) PRIVATE LIMITED

• Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, acquired 100% stake in A1 Biochem Labs (India) Private Limited in July 2026. • Dr. Rajendra Gadikota, former promoter of A1 Biochem group, subscribed to 89,94,500 equity shares and 2,41,05,500 Compulsory Convertibles Debentures of A1 Labs. • This allotment represents a 20% stake in A1 Labs on a fully diluted basis, post which A1 Labs is no longer a wholly-owned subsidiary of Apitoria. • The consideration received by A1 Labs was INR 9.18 Cr for equity shares and INR 24.62 Cr for Compulsory Convertible Debentures. • Dr. Rajendra Gadikota is a director of A1 Labs and the transaction is considered a related party transaction conducted at arm's length. • The transaction was approved by A1 Labs' shareholders via special resolution based on a fair valuation report.

Aurobindo Pharma Limited

Open attachment

← Back to feed